Pritelivir
- Generic Name
- Pritelivir
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H18N4O3S2
- CAS Number
- 348086-71-5
- Unique Ingredient Identifier
- 07HQ1TJ4JE
- Background
Pritelivir has been used in trials studying the prevention of HSV-2 and Genital Herpes.
- Associated Conditions
- -
- Associated Therapies
- -
Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects With Treatment Resistant Herpes Simplex Virus Type 1 or 2
- Conditions
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- AiCuris Anti-infective Cures AG
- Registration Number
- NCT05844436
Potential Influence of Esomeprazole on the Pharmacokinetics of Pritelivir
- First Posted Date
- 2022-08-24
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- AiCuris Anti-infective Cures AG
- Target Recruit Count
- 16
- Registration Number
- NCT05513625
- Locations
- 🇺🇸
Medpace Clinical Pharmacology, Cincinnati, Ohio, United States
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects
- First Posted Date
- 2017-03-08
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- AiCuris Anti-infective Cures AG
- Target Recruit Count
- 153
- Registration Number
- NCT03073967
- Locations
- 🇩🇪
Universitätsklinikum Essen, Essen, Germany
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸University Arizona - Department of Medicine Arizona Health Sciences Center, Tucson, Arizona, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath